Katy Rezvani, MD Anderson
CAR NK therapy looks durable in a small trial, giving insight into large Takeda study
An “off-the-shelf” cell therapy engineered using natural killer cells resulted in lasting responses in a small clinical trial for certain lymphomas and leukemia, according to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.